Search
for
Sort by
Research 241–270 of 1000+
- An exploratory analysis of 5‐alpha reductase inhibitors and risk of opioid use disorder among male Medicare beneficiaries receiving prescription opioid medications
- 24-Hydroxycholesterol suppresses steroid 5α-reductase-catalyzed conversion in human glioblastoma cell lines: A novel link between brain cholesterol homeostasis and androgen metabolism
- Identification of xenobiotics interfering with 5 <mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" display="inline" id="d1e152" altimg="si21.svg"> <mml:mi>α</mml:mi> </mml:math> -reductase (SRD5A2) activity
- Intracrine and Myotrophic Roles of 5α-Reductase and Androgens
- Long-Term Experience With 5-alpha-Reductase Inhibitors.
- Extensive Challenges and Pending Advances in the Study of 5-Alpha-Reductase Isoenzymes. A Literature Review
- Androgens and Parkinson’s disease: the role in humans and in experiment
- Peripheral Neuroprotective and Immunomodulatory Effects of 5α-Reductase Inhibitors in Parkinson’s Disease Models
- Persistent erectile dysfunction in men exposed to the 5α-reductase inhibitors, finasteride, or dutasteride
- Investigation of the Plausibility of 5-Alpha-Reductase Inhibitor Syndrome
- Sebaceous gland abnormalities in fatty acyl CoA reductase 2 (Far2) null mice result in primary cicatricial alopecia
- Female pattern hair loss in men: A distinct clinical variant of androgenetic alopecia
- Comparative efficacy of topical finasteride (0.25%) in combination with minoxidil (5%) against 5% minoxidil or 0.25% finasteride alone in male androgenetic alopecia: A pilot, randomized open-label study
- The Effect of Finasteride in Men with Benign Prostatic Hyperplasia
- Comparative Study of effectiveness of low dose Oral Minoxidil vs Topical Minoxidil (5%) in Male Androgenetic Alopecia.
- 2-Substituted 4-(Thio)chromenone 6-<i>O</i>-Sulfamates: Potent Inhibitors of Human Steroid Sulfatase
- Oral Presentations: Abstracts of the Urological Society of Australia and New Zealand Annual Scientific Meeting, 25–28 February 2023, Melbourne, Australia
- The clinical applications of five-alpha reductase inhibitors.
- 5α-Reductase Isoenzymes: From Neurosteroid Biosynthesis to Neuropsychiatric Outcomes
- 5α-Reductases in Human Physiology: An Unfolding Story
- Skin-specific regulation of SREBP processing and lipid biosynthesis by glycerol kinase 5
- Androgens and hair: a biological paradox
- Attenuating 5α-pregnane-3α-ol-20-one formation in the hippocampus of female rats increases pentylenetetrazole-induced seizures
- The enzyme and inhibitors of 4-ene-3-oxosteroid 5α-oxidoreductase
- Synthesis and Actions of 5α-Reduced Metabolites of Testosterone in the Nervous System
- Analysis of metabolic characteristics of epristeride in zebrafish based on LC-Q-TOF MS and its potential applications in doping control
- Effect of finasteride on the ovulatory function of normal women
- Effect of finasteride in idiopathic hirsutism
- Relationships between cerebrospinal fluid GABAergic neurosteroid levels and symptom severity in men with PTSD
- Molecular Mechanisms and Therapeutic Advances in Androgenetic Alopecia